November 8, 2014
Notes: Bale, Jessica
Australas J Dermatol. 2014 Aug;55(3):191-5. doi: 10.1111/ajd.12097. Epub 2013 Aug 29.
Author Address: Department of Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia.
Reference Type: Journal Article
Record Number: 4259Author: Bamba, S., Barro-Traore, F., Drabo, M. K., Gouba, A., Traore, A. and Guiguemde, T. R.
Title: [Epidemiological profile, clinical and therapeutic cutaneous leishmaniasis in the Department of Dermatology at University Hospital in Ouagadougou, Burkina Faso]
Journal: Rev Med Brux
Short Title: [Epidemiological profile, clinical and therapeutic cutaneous leishmaniasis in the Department of Dermatology at University Hospital in Ouagadougou, Burkina Faso]
Alternate Journal: Revue medicale de Bruxelles
ISSN: 0035-3639 (Print)
Original Publication: Profil epidemiologique, clinique et therapeutique de la leishmaniose cutanee dans le Service de Dermatologie du Centre Hospitalier Universitaire de Ouagadougou, Burkina Faso.
Accession Number: 24303652
Aged, 80 and over
Hospital Departments/statistics & numerical data
Hospitals, University/statistics & numerical data
Abstract: It is a retrospective study in the Service of Dermatology at the University Hospital Center Yalgado Ouedraogo of Ouagadougou (C.H.U.-YO). This study aimed to list the leishmaniasis clinical cases reported in the registers of this department from January 1999 to December 2007. In total, 251 leishmaniasis clinical cases have been reported. The hospital prevalence was 1,1%. Women represented 53% versus 47% men. The average age of patients was 22,78 ans +/- 121. The most frequent clinical forms were those often crusted (40.2%), papulo ulcerative (16.7%) and papulonodular (13.9%). Lesions most often sat on the lower limbs (33%) and thoracic limbs (45%). On the therapeutic level, the first line treatment meglumine antimonite (Glucantime) accounted for only 25.9% of prescriptions.